Header cover image

Household Healthcare Sector

Results

2306

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2306 companies

TransMedics Group

Market Cap: US$4.2b

A commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

TMDX

US$121.31

7D

-0.9%

1Y

-11.4%

Bausch + Lomb

Market Cap: US$4.2b

Operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally.

BLCO

US$11.19

7D

-3.1%

1Y

-23.9%

BrightSpring Health Services

Market Cap: US$4.2b

Operates as a home and community-based healthcare services platform in the United States.

BTSG

US$23.74

7D

1.1%

1Y

106.8%

Rhythm Pharmaceuticals

Market Cap: US$4.1b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

RYTM

US$62.41

7D

9.0%

1Y

64.9%

Sarepta Therapeutics

Market Cap: US$3.9b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

SRPT

US$40.05

7D

12.1%

1Y

-68.8%

Cytokinetics

Market Cap: US$3.9b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

CYTK

US$31.31

7D

4.4%

1Y

-47.1%

Avidity Biosciences

Market Cap: US$3.8b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

RNA

US$30.62

7D

7.8%

1Y

3.4%

Krystal Biotech

Market Cap: US$3.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

KRYS

US$126.68

7D

-3.6%

1Y

-25.2%

Akero Therapeutics

Market Cap: US$3.8b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

AKRO

US$48.35

7D

27.6%

1Y

135.9%

Soleno Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

SLNO

US$73.30

7D

-0.2%

1Y

71.0%

Perrigo

Market Cap: US$3.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

PRGO

US$26.91

7D

3.5%

1Y

-8.3%

PTC Therapeutics

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

PTCT

US$46.21

7D

-1.2%

1Y

19.6%

Chartwell Retirement Residences

Market Cap: CA$5.1b

Chartwell is in the business of serving and caring for Canada's seniors, committed to its vision of Making People's Lives BETTER and to providing a happier, healthier, and more fulfilling life experience for its residents.

CSH.UN

CA$17.75

7D

-0.2%

1Y

41.5%

Sotera Health

Market Cap: US$3.6b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

SHC

US$12.34

7D

-3.7%

1Y

9.7%

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$21.85

7D

27.3%

1Y

38.1%

Zai Lab

Market Cap: US$3.5b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

ZLAB

US$32.59

7D

15.8%

1Y

61.7%

Ultragenyx Pharmaceutical

Market Cap: US$3.5b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

RARE

US$35.41

7D

2.0%

1Y

-13.8%

SpringWorks Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

SWTX

US$46.21

7D

-0.02%

1Y

4.4%

Haemonetics

Market Cap: US$3.5b

A healthcare company, provides suite of medical products and solutions in the United States and internationally.

HAE

US$66.92

7D

-2.5%

1Y

-25.7%

1Life Healthcare

Market Cap: US$3.4b

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.

ONEM

US$16.47

7D

7.3%

1Y

68.8%

CRISPR Therapeutics

Market Cap: US$3.4b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

CRSP

US$36.99

7D

3.9%

1Y

-34.9%

Arcellx

Market Cap: US$3.3b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

ACLX

US$65.54

7D

11.0%

1Y

20.8%

DENTSPLY SIRONA

Market Cap: US$3.3b

Develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.

XRAY

US$15.83

7D

-3.8%

1Y

-43.6%

ICU Medical

Market Cap: US$3.3b

Develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.

ICUI

US$130.75

7D

-3.8%

1Y

23.8%

PROCEPT BioRobotics

Market Cap: US$3.3b

A surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally.

PRCT

US$56.64

7D

3.4%

1Y

-15.5%

Viking Therapeutics

Market Cap: US$3.2b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

VKTX

US$27.25

7D

2.6%

1Y

-56.8%

Amedisys

Market Cap: US$3.1b

Provides healthcare services in the United States.

AMED

US$93.59

7D

-0.9%

1Y

-3.3%

Alignment Healthcare

Market Cap: US$3.1b

Operates a consumer-centric healthcare platform for seniors in the United States.

ALHC

US$15.33

7D

2.8%

1Y

106.6%

Metsera

Market Cap: US$3.1b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

MTSR

US$28.68

7D

17.1%

1Y

n/a

Merus

Market Cap: US$3.0b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

MRUS

US$43.21

7D

7.0%

1Y

-0.4%

Ansell

Market Cap: AU$4.7b

Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.

ANN

AU$31.69

7D

-1.9%

1Y

24.7%

Envista Holdings

Market Cap: US$3.0b

Develops, manufactures, markets, and sells dental products in the United States, China, and internationally.

NVST

US$16.64

7D

-7.2%

1Y

-10.7%

Catalyst Pharmaceuticals

Market Cap: US$3.0b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

CPRX

US$24.32

7D

3.9%

1Y

50.7%

Scholar Rock Holding

Market Cap: US$3.0b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

SRRK

US$30.72

7D

0.6%

1Y

162.3%

Privia Health Group

Market Cap: US$3.0b

Operates as a national physician-enablement company in the United States.

PRVA

US$23.80

7D

-2.1%

1Y

44.8%

Surgery Partners

Market Cap: US$3.0b

Owns and operates a network of surgical facilities and ancillary services in the United States.

SGRY

US$22.67

7D

-0.4%

1Y

-10.0%

Page 5 of 65